Results 41 to 50 of about 26,501 (228)

Repeated transarterial chemoembolization: An overfitting effort?

Journal of Hepatology, 2015
n ...
A. Facciorusso, S. Bhoori, C. Sposito, V. Mazzaferro   +3 more
openaire   +3 more sources

Transarterial chemoembolization of hepatocellular carcinoma

Journal of Current Research in Scientific Medicine, 2021
Aims And Objectives: We evaluated the role of Dyna CT in localizing HCC lesions and their selective vascular supply to help guide chemoembolization. We also evaluated the role of Dyna CT in assessing drug deposition within the lesion and predict the need of further drug delivery. Methods:
Manzoor Hussain, Tahleel Shera, Omair Ashraf Shah, Naseer Choh, Feroze Shaheen, Tariq Gojwari, Gull Mohammad Bhat, G. M. Gulzar   +7 more
openaire   +1 more source

Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2019
Aim. To evaluate the efficacy of transarterial chemoembolization in patients with metastases of colorectal cancer in the liver.Materials and methods. A study aimed at investigating the effect of selective transarterial chemoembolization (TACE) of the ...
O. Yu. Stukalova, G. P. Gens, Z. Kh. Shugushev, V. V. Maslov, A. G. Chepurnoy   +4 more
doaj   +1 more source

Liver Abscess Following Transarterial Chemoembolization [PDF]

Seminars in Interventional Radiology, 2011
Transarterial chemoembolization (TACE) alone or in combination with thermoablation is commonly used in treating primary and secondary liver malignancies.1,2 It has proven to be safe and effective in treating hepatocellular carcinoma (HCC), neuroendocrine tumors, ocular melanoma, cholangiocarcinoma, and sarcoma.
openaire   +2 more sources

Comparison of Callisphere Drug-Eluting Beads Transarterial Chemoembolization and Conventional Transarterial Chemoembolization for the treatment of Hepatocellular Carcinoma

Pakistan Journal of Medical Sciences, 2023
Objective: To compare the efficacy of CalliSphere drug-eluting beads (DEBs) and conventional (c) transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC). Methods: We retrospectively reviewed the clinical data of 125 patients with HCC who had received treatment in Affiliated Hospital of North Sichuan Medical College ...
Ren, Yongjun, Zhao, Caixia, Xiong, Yongfu, Liu, Zhongbai, Wu, Guo   +4 more
openaire   +2 more sources

Transarterial chemoembolization using drug eluting microspheres in refractory colorectal liver metastases with 18F-FDG PET/CT follow-up to assess therapeutic response

The Egyptian Journal of Radiology and Nuclear Medicine, 2016
Purpose: The purpose of this study was to evaluate the efficiency of transarterial chemoembolization using drug eluting microspheres loaded with irinotecan in the treatment of the colorectal liver metastases after failure of chemotherapy.
Mohamed G. Mansour, MD, Susan A. Ali, MD
doaj   +1 more source

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials

Technology in Cancer Research & Treatment, 2022
Purpose: Sorafenib is recommended for patients with hepatocellular carcinoma refractory to transarterial chemoembolization but with unsatisfactory overall survival and tumor response rate.
YeXing Huang MD, LiHong Zhang MD, MinKe He MD, ZhiCheng Lai MD, XiaoYun Bu MD, DongSheng Wen MD, QiJiong Li MD, Li Xu MD, Wei Wei MD, YaoJun Zhang MD, ZhongGuo Zhou MD, MinShan Chen MD, RongPing Guo MD, Ming Shi MD, Anna Kan MD   +14 more
doaj   +1 more source

The treatment of transarterial chemoembolization/hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitor is effective against hepatocellular carcinoma with portal vein tumor thrombus: A systematic review

Frontiers in Oncology, 2023
BackgroundLenvatinib combined with programmed cell death protein-1 inhibitor has achieved good survival results in the treatment of hepatocellular carcinoma with portal vein tumor thrombus.
Gao Yuanren, Linan Yin, Ruibao Liu, Yali Cui   +3 more
doaj   +1 more source

Single‐Dose TACE‐Like Injection of Sustained‐Release Panobinostat/IL‐12 Polymeric Microparticles is Effective in Preclinical Liver Cancer Models

Advanced Science, EarlyView.
A novel PLGA/PBAE polymer microparticle platform revolutionizes intermediate‐stage liver cancer treatment by co‐delivering panobinostat and IL‐12 via a single TACE‐like injection. This sustained‐release system overcomes tumor immunosuppression, triggers robust innate and adaptive immune responses, and establishes tertiary lymphoid structures ...
Hongzhe Yu, Ling Li, Sachin S. Surwase, Xin Ming M. Zhou, Hongtao Qian, Joel C. Sunshine, Florin M. Selaru, Jordan J. Green   +7 more
wiley   +1 more source

Rapid aneurysm growth after transarterial chemoembolization [PDF]

, 2015
Chemotherapy has been anecdotally related to aneurysm growth, but no correlation has been noted to date for localized transarterial chemoembolization. We present the case of a 64-year-old man with clearly documented accelerated aortic and iliac artery ...
Shames, Murray, Dansey, Kirsten, Powell, Alexis, Rodriguez, Eduardo, Wooster, Mathew, Zwiebel, Bruce   +5 more
core   +1 more source